ACMD report updates

As well as yesterday’s news item on etomidate, the Advisory Council on the Misuse of Drugs published Amendment to ACMD report – Use and harms of xylazine, medetomidine and detomidine and 6th addendum to ACMD report on the use and harms of 2-benzyl benzimidazole (‘nitazene’) and piperidine benzimidazolone (‘brorphine-like’) opioids.